We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Pancreatic Cancer: Less Toxic Drug May Improve Therapy

News   Aug 09, 2019 | Original story from Columbia University Irving Medical Center

 
Pancreatic Cancer: Less Toxic Drug May Improve Therapy

In preclinical testing, an experimental drug for pancreatic cancer blocks the formation of microtubules in the cell, hindering growth. Microtubules are shown in black, and DNA is in blue. The pancreatic cancer cluster on the right was treated with PTC596. Credit: PTC Therapeutics

 
 
 

RELATED ARTICLES

Potential Cancer Players Uncovered by Tumor Protein Analysis

News

Looking to gain a deeper understanding of cancer, a team conducted an extensive computational analysis of the similarities and differences in the entire set of proteins, called the proteome, of more than 500 cancers from five different tissue sites.

READ MORE

The Dangers Lurking Behind Certain Biologics

News

The surprising role of an immune cell that explains some of biologic drugs' side effects could lead to better treatments for persistent infections and cancer.

READ MORE

The Right Mouse Is Key for Huntington's Drug Development

News

Scientists evaluated mouse models used for developing new treatments for mood disorders associated with Huntington's disease and recommend which are most relevant and have greater potential for success.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE